146 related articles for article (PubMed ID: 36220845)
61. The Choroid after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
Christou EE; Katsanos A; Georgalas I; Kozobolis V; Kalogeropoulos C; Stefaniotou M
Acta Medica (Hradec Kralove); 2022; 65(3):89-98. PubMed ID: 36735886
[TBL] [Abstract][Full Text] [Related]
62. Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.
van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Blanco-Garavito R; Souied EH; Keunen JEE; MacLaren RE; Querques G; Fauser S; Downes SM; Hoyng CB; Boon CJF
Am J Ophthalmol; 2019 Sep; 205():1-10. PubMed ID: 30951686
[TBL] [Abstract][Full Text] [Related]
63. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy.
Xu Y; Su Y; Li L; Qi H; Zheng H; Chen C
Ophthalmologica; 2017; 237(3):167-172. PubMed ID: 28171871
[TBL] [Abstract][Full Text] [Related]
64. [Choroidal thickness after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy].
Zeng J; Yan YY; Ding XY; Liu R; Li JQ
Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):490-4. PubMed ID: 24119960
[TBL] [Abstract][Full Text] [Related]
65. Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy.
Nicoló M; Eandi CM; Alovisi C; Grignolo FM; Traverso CE; Musetti D; Cardillo Piccolino F
Am J Ophthalmol; 2014 May; 157(5):1033-7. PubMed ID: 24487046
[TBL] [Abstract][Full Text] [Related]
66. Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy.
Tseng CC; Chen SN
Br J Ophthalmol; 2015 Aug; 99(8):1070-7. PubMed ID: 25680621
[TBL] [Abstract][Full Text] [Related]
67. Photodynamic Therapy with Chlorin e6 Derivative for Chronic Central Serous Chorioretinopathy (Pilot Study).
Kustryn T; Zadorozhnyy O; Nasinnyk I; Korol A; Pasyechnikova N
J Ocul Pharmacol Ther; 2022 Sep; 38(7):505-512. PubMed ID: 35687410
[No Abstract] [Full Text] [Related]
68. Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy.
Nishigori N; Muraoka Y; Ishikura M; Kogo T; Ueda-Arakawa N; Miyata M; Tamura H; Hata M; Takahashi A; Miyake M; Tsujikawa A
Sci Rep; 2023 Jul; 13(1):10890. PubMed ID: 37407690
[TBL] [Abstract][Full Text] [Related]
69. Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.
Arevalo JF; Espinoza JV
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1159-66. PubMed ID: 21448811
[TBL] [Abstract][Full Text] [Related]
70. Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy.
Linghu D; Xu H; Liang Z; Gao T; Lin Z; Li X; Huang L; Zhao M
Int Ophthalmol; 2020 Apr; 40(4):951-956. PubMed ID: 31925659
[TBL] [Abstract][Full Text] [Related]
71. Optimal fluence rate of photodynamic therapy for chronic central serous chorioretinopathy.
Park DG; Jeong S; Noh D; Sagong M
Br J Ophthalmol; 2021 Jun; 105(6):844-849. PubMed ID: 32727733
[TBL] [Abstract][Full Text] [Related]
72. Long-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Rouvas A; Stavrakas P; Theodossiadis PG; Stamatiou P; Milia M; Giannakaki E; Datseris I
Eur J Ophthalmol; 2012; 22(3):417-22. PubMed ID: 21928269
[TBL] [Abstract][Full Text] [Related]
73. CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Early and Late Morphological and Functional Changes After Verteporfin Photodynamic Therapy.
Iacono P; Tedeschi M; Boccassini B; Chiaravalloti A; Varano M; Parravano M
Retina; 2019 May; 39(5):980-987. PubMed ID: 29346241
[TBL] [Abstract][Full Text] [Related]
74. Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report.
Liu Y; Wang X; Zhu M; Xu G; Li L
BMC Ophthalmol; 2019 Mar; 19(1):68. PubMed ID: 30849939
[TBL] [Abstract][Full Text] [Related]
75. PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors.
Hwang S; Kang SW; Kim SJ; Jang JW; Kim KT
Retina; 2019 Jun; 39(6):1117-1124. PubMed ID: 29517581
[TBL] [Abstract][Full Text] [Related]
76. Fluorescein angiography as a primary guide for reduced-fluence photodynamic therapy for the treatment of chronic central serous chorioretinopathy.
Koytak A; Bayraktar H; Ozdemir H
Int Ophthalmol; 2020 Jul; 40(7):1807-1813. PubMed ID: 32274613
[TBL] [Abstract][Full Text] [Related]
77. Longitudinal multimodal functional macular analysis after half-dose photodynamic therapy for central serous chorioretinopathy.
Penas S; Beato J; Rosinha P; Araújo J; Costa A; Carneiro Â; Falcão-Reis F; Rocha-Sousa A
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102704. PubMed ID: 34954386
[TBL] [Abstract][Full Text] [Related]
78. A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial.
Zhao M; Zhang F; Chen Y; Dai H; Qu J; Dong C; Kang X; Liu Y; Yang L; Li Y; Zhou P; Pan CT; Zhang L; Liu P; Zhou H; Jiao X; Xiong Y; Tian R; Lu Y; Yu X; Li X
JAMA Ophthalmol; 2015 Mar; 133(3):333-40. PubMed ID: 25555191
[TBL] [Abstract][Full Text] [Related]
79. CHOROIDAL NEOVASCULARIZATION SECONDARY TO PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHY: Incidence, Risk Factors, and Clinical Outcomes.
Hwang S; Noh H; Kang SW; Kang MC; Lee D; Kim SJ
Retina; 2021 Aug; 41(8):1762-1770. PubMed ID: 33315827
[TBL] [Abstract][Full Text] [Related]
80. OCTA evaluation of treatment-naïve flat irregular PED (FIPED)-associated CNV in chronic central serous chorioretinopathy before and after half-dose PDT.
Guo J; Tang W; Xu S; Liu W; Xu G
Eye (Lond); 2021 Oct; 35(10):2871-2878. PubMed ID: 33323982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
